Krystal Biotech, Inc. KRYS Net Income
Net Income at other companies
Segments
By segment
See fullOther financials
Where this comes from
Reported directly by Krystal Biotech, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetIncomeLoss.
The official record: Krystal Biotech, Inc.’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Krystal Biotech, Inc.'s net income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Krystal Biotech, Inc.'s net income?
- Krystal Biotech, Inc. (KRYS) reported net income of $55.93M in Q1 2026.
- How has Krystal Biotech, Inc.'s net income changed year-over-year?
- Krystal Biotech, Inc.'s net income increased by 56.5% year-over-year, from $35.73M to $55.93M.
- What is the long-term trend for Krystal Biotech, Inc.'s net income?
- Over 4 years (2021 to 2025), Krystal Biotech, Inc.'s net income has grown at a 31.0% compound annual growth rate (CAGR), from -$69.57M to $204.83M.
- What does net income mean?
- The total accounting profit earned by the company during the period.
- How do you interpret net income?
- An increase indicates higher profitability and potential for reinvestment, while a decrease may signal operational challenges or rising costs.
- How does net income compare across companies?
- Standard across all public companies; essential for calculating net profit margins and earnings per share.